LEADER 01345nam  2200385Ia 450 
001 9910698125803321
005 20090324151211.0
035   $a(CKB)5470000002395725
035   $a(OCoLC)316875920
035   $a(EXLCZ)995470000002395725
100   $a20090324d2008      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $epotency tests for cellular and gene therapy products
210  1$a[Rockville, MD] :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2008]
215   $ai, 15 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Mar. 24, 2009).
300   $a"Draft guidance."
300   $a"October 2008."
300   $aIncludes bibliographical references (p. 14-15).
517   $aGuidance for industry 
606   $aCellular therapy$xTesting
606   $aGene therapy$xTesting
615  0$aCellular therapy$xTesting.
615  0$aGene therapy$xTesting.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698125803321
996   $aGuidance for industry$93434577
997   $aUNINA